These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 24851608)
1. Association study of cytochrome P450 1A1*2A polymorphism with prostate cancer risk and aggressiveness in Croatians. Mandić S; Horvat V; Marczi S; Lukić I; Galić J Coll Antropol; 2014 Mar; 38(1):141-6. PubMed ID: 24851608 [TBL] [Abstract][Full Text] [Related]
2. Lack of association of CYP1A1 polymorphism with prostate cancer susceptibility of Tunisian men. Souiden Y; Mahdouani M; Chaieb K; Bakhrouf A; Mahdouani K Genet Test Mol Biomarkers; 2012 Jul; 16(7):661-6. PubMed ID: 22304463 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer. Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612 [TBL] [Abstract][Full Text] [Related]
4. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population. Aktas D; Hascicek M; Sozen S; Ozen H; Tuncbilek E Cancer Genet Cytogenet; 2004 Oct; 154(1):81-5. PubMed ID: 15381379 [TBL] [Abstract][Full Text] [Related]
5. Association of IL-1β and IL-10 Polymorphisms with Prostate Cancer Risk and Grade of Disease in Eastern Croatian Population. Horvat V; Mandić S; Marczi S; Mrčela M; Galić J Coll Antropol; 2015 Jun; 39(2):393-400. PubMed ID: 26753456 [TBL] [Abstract][Full Text] [Related]
6. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer. Zambra FM; Biolchi V; Brum IS; Chies JA Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061 [TBL] [Abstract][Full Text] [Related]
7. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10. Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900 [TBL] [Abstract][Full Text] [Related]
8. Androgen receptor GGC polymorphism and testosterone levels associated with high risk of prostate cancer and benign prostatic hyperplasia. Biolchi V; Silva Neto B; Pianta DB; Koff WJ; Berger M; Brum IS Mol Biol Rep; 2013 Mar; 40(3):2749-56. PubMed ID: 23184046 [TBL] [Abstract][Full Text] [Related]
9. Association of G/A polymorphism, rs266882, in AREI region of the prostate-specific antigen gene with prostate cancer risk and clinicopathological features. Samzadeh M; Hasanzad M; Jamaldini SH; Haghdoost AA; Afshari M; Ziaee SA Urol J; 2012; 9(4):691-9. PubMed ID: 23235975 [TBL] [Abstract][Full Text] [Related]
10. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men. Takahashi H; Lu W; Watanabe M; Katoh T; Furusato M; Tsukino H; Nakao H; Sudo A; Suzuki H; Akakura K; Ikemoto I; Asano K; Ito T; Wakui S; Muto T; Hano H Int J Cancer; 2003 Nov; 107(2):224-8. PubMed ID: 12949798 [TBL] [Abstract][Full Text] [Related]
11. Lack of evidence of HPV etiology of prostate cancer following radical surgery and higher frequency of the Arg/Pro genotype in Turkish men with prostate cancer. Aydin M; Bozkurt A; Cikman A; Gulhan B; Karabakan M; Gokce A; Alper M; Kara M Int Braz J Urol; 2017; 43(1):36-46. PubMed ID: 28124524 [TBL] [Abstract][Full Text] [Related]
12. Association of caspases with an increased prostate cancer risk in north Indian population. Mittal RD; Mittal T; Singh AK; Mandal RK DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377 [TBL] [Abstract][Full Text] [Related]
13. Association of codon 10 polymorphism of the transforming growth factor beta 1 gene with prostate cancer and hyperplasia in an Iranian population. Omrani MD; Taghipour-Bazargani S; Salari-Lak S; Bagheri M Urol Int; 2009; 83(3):329-32. PubMed ID: 19829035 [TBL] [Abstract][Full Text] [Related]
14. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women. Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674 [TBL] [Abstract][Full Text] [Related]
15. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort. Srivastava P; Kapoor R; Mittal RD Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201 [TBL] [Abstract][Full Text] [Related]
16. An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population. Dargahi Abbasabad G; Banan Khojasteh SM; Eskandari Naji H; Zamani MR; Hajipour H; Serati-Nouri H Asian Pac J Cancer Prev; 2018 Jun; 19(6):1717-1720. PubMed ID: 29938471 [TBL] [Abstract][Full Text] [Related]
17. CYP 1A1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancer. Kumar V; Yadav CS; Singh S; Goel S; Ahmed RS; Gupta S; Grover RK; Banerjee BD Chemosphere; 2010 Sep; 81(4):464-8. PubMed ID: 20817259 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 polymorphism and prostate cancer risk in population of Eastern Croatia. Mandić S; Sudarević B; Marczi S; Horvat V; Cosić I; Mihaljević S; Milicević N; Simunović D; Galić J Coll Antropol; 2013 Sep; 37(3):907-11. PubMed ID: 24308236 [TBL] [Abstract][Full Text] [Related]
19. Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significance. Avgeris M; Stravodimos K; Scorilas A Prostate; 2011 Dec; 71(16):1780-9. PubMed ID: 21520157 [TBL] [Abstract][Full Text] [Related]
20. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3. Safarinejad MR; Shafiei N; Safarinejad S Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]